Press Archives

Press

ERA4TB participates in the #WorldEBHCDay campaign, ‘Partnerships for Purpose’

The article ‘How partnerships are driving new treatments for tuberculosis’ has just been published on World…

Andrea GarciaSeptember 21, 2022

Press

Advancing Clinical Research Capacity in Europe: Almari Conradie on TBAJ-587 and the ERA4TB Project [TB Alliance]

TBAJ-587-CL-001 is the first Phase 1 trial in humans conducted by TB Alliance through the…

Inari SoininenNovember 26, 2021

Press

COVID-19 highlights urgent need to reboot global effort to end tuberculosis [Press Release – WHO]

An estimated 1.4 million fewer people received care for tuberculosis (TB) in 2020 than in…

Inari SoininenMarch 26, 2021

Press

ERA4TB Press Release

Innovative Medicines Initiative Launches European Regimen Accelerator For Tuberculosis (ERA4TB) project.

adminJanuary 29, 2020

Press

ERA4TB

European Regimen Accelerator For Tuberculosis (ERA4TB) project starts.

adminJanuary 28, 2020

TWITTER

ERA4TB ProjectFollow

Research consortium developing new treatments for TB European Regimen Accelerator for Tuberculosis Grant Agreement no. 853989 — ERA4TB https://t.co/BXboc1TV3r

26 Jan

🎉As the 6th ERA4TB Consortium Meeting in Paris comes to an end we'd like to thank all participants for another successful event! We look forward to continuing our work towards better TB treatments over the next 3 years and to our next consortium meeting this summer!

#TB #H2020

Reply on Twitter 1618622786263715842 Retweet on Twitter 161862278626371584211 Like on Twitter 161862278626371584228 Twitter 1618622786263715842

26 Jan

We conclude the 6th consortium meeting with comments from Gilla Kaplan and Francesca Conradie, our external Scientific Advisory Board members

We thank all the Consortium and SAB members for their excellent contributions!

#Tuberculosis #EUHealthResearch #H2020

Reply on Twitter 1618610944896294916 Retweet on Twitter 16186109448962949165 Like on Twitter 161861094489629491613 Twitter 1618610944896294916

26 Jan

Today, the 6th Consortium Meeting of ERA4TB started with an overview of the pipeline status and discussions on each asset’s progression

#Tuberculosis #EUHealthResearch #H2020

Reply on Twitter 1618528773623906304 Retweet on Twitter 16185287736239063049 Like on Twitter 161852877362390630417 Twitter 1618528773623906304

Retweet on Twitter ERA4TB Project Retweeted

25 Jan

The management team of @IMI_ERA4TB, Carlos Díaz and Elena del Rey led a session on project management and sustainability at the 6th Consortium Meeting in Paris

@IHIEurope #Tuberculosis #EUHealthResearch #H2020

Reply on Twitter 1618338498993586176 Retweet on Twitter 16183384989935861765 Like on Twitter 161833849899358617610 Twitter 1618338498993586176

25 Jan

We finish the first day of the meeting with strong contributions made by the ERA4TB partners. Thanks to all! We look forward to hearing more updates tomorrow

@IHIEurope @ServInvestUC3M @institutpasteur @GSK_ES

#Tuberculosis #EUHealthResearch #H2020

Reply on Twitter 1618278148969496576 Retweet on Twitter 16182781489694965767 Like on Twitter 161827814896949657619 Twitter 1618278148969496576

Press

ERA4TB participates in the #WorldEBHCDay campaign, ‘Partnerships for Purpose’

Advancing Clinical Research Capacity in Europe: Almari Conradie on TBAJ-587 and the ERA4TB Project [TB Alliance]

COVID-19 highlights urgent need to reboot global effort to end tuberculosis [Press Release – WHO]

ERA4TB Press Release

ERA4TB

Recent Posts

Categories

TWITTER

Acknowledgement:

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853989.

The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and Global Alliance for TB Drug Development non profit organisation, Bill & Melinda Gates Foundation and University of Dundee.

Contact:

info@era4tb.org

The Project

Consortium

News

Result